SimulatED: Using Continuous Glucose Monitoring Data to Improve Health Outcomes

This activity was originally broadcast during the PTCE Diabetes Day of Education on May 21, 2024.

Program Description:

This activity consists of several patient case simulations, SimulatED™. During the SimulatED™ activity, participants will have the opportunity to apply learnings from CGM technologies and engage in an interactive platform that simulates a clinical educational experience, complete with virtual patient encounters. The faculty will then run through case-based discussions in which analytics and the treatment decision-making process will be reviewed.

Target audience: Retail pharmacists

Type of activity: Application
Release date: July 26, 2024
Expiration date: July 26, 2025

Time to complete activity: 0.75 hour

Learner level: Advanced
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Identify people with diabetes who may benefit from continuous glucose monitoring (CGM)
• Explore counseling points when speaking with people with diabetes about appropriate use and interpretation of CGM data to inform self-management and care decisions
• Analyze CGM data to inform changes to glucose-lowering therapies to optimize care and outcomes for people with diabetes

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-24-228-H01-P. The activity is available for CE credit through July 26, 2025.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, has the following financial relationships with commercial interests to disclose:
Consultant: Bayer, Boehringer Ingelheim, Eli Lilly, Proteomics International

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Crissy Wilson; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms